Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis

Journal of Urology

Volumn 170, Issue 4 I, 2003, Pages 1155-1158

  Pohar, Kamal S ^a   Rabbani, Farhang ^a   Bosl, George J ^a   Motzer, Robert J ^a   Bajorin, Dean ^a   Sheinfeld, Joel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Carcinoma, embryonal; Lymph node excision, retroperitoneal space

Indexed keywords

CISPLATIN; IFOSFAMIDE; PACLITAXEL;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYONAL CARCINOMA; FOLLOW UP; GERM CELL TUMOR; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; MALE; PARAAORTIC LYMPH NODE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROPERITONEAL DISEASE; TESTIS CARCINOMA;

EID: 0042692984     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000087796.63505.70     Document Type: Article

References (23)

1. Hermans, B. P., Sweeney, C. J., Foster, R. S., Einhorn, L. E. and Donohue, J. P.: Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol, 163: 1721, 2000
2. Aass, N., Fossa, S. D., Ous, S., Lien, H. H., Stenwig, A. E., Paus, E. et al: Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage nonseminomatous testicular cancer? Br J Urol, 65: 385, 1990
3. Heidenreich, A., Sesterhenn, I. A., Mostofi, F. K. and Moul, J. W.: Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer, 83: 1002, 1998
4. Klepp, O., Olsson, A. M., Henrikson, H., Aass, N., Dahl, O., Stenwig, A. E. et al: Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group. J Clin Oncol, 8: 509, 1990
5. McLeod, D. G., Weiss, R. B., Stablein, D. M., Muggia, F. M., Paulson, D. F., Ellis, J. H. et al: Staging relationships and outcome in early stage testicular cancer: a report from the testicular cancer intergroup study. J Urol, 145: 1178, 1991
6. Moul, J. W., McCarthy, W. F., Fernandez, E. B. and Sesterhenn, I. A.: Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res, 54: 362, 1994
7. Pizzocaro, G., Zanoni, F., Salvioni, R., Milani, A., Piva, L. and Pilotti, S.: Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis. J Urol, 138: 1393, 1987
8. Sturgeon, J. F., Jewett, M. A., Alison, R. E., Gospodarowicz, M. K., Blend, R., Herman, S. et al: Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. J Clin Oncol, 10: 564, 1992
9. Sesterhenn, I. A., Weiss, R. B., Mostofi, F. K., Stablein, D. M., Rowland, R. G., Falkson, G. et al: Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol, 10: 69, 1992
10. Bosl, G. J. and Motzer, R. J.: Testicular germ-cell cancer. N Engl J Med, 337: 242, 1997
11. Houldsworth, J., Heath, S. C., Bosl, G. J., Studer, L. and Chaganti, R. S.: Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells. Cell Growth Differ, 13: 257, 2002
12. Fleming, I. D., Cooper, J. S., Hensen, D. E., Hutter, R. V. P., Kennedy, B. J., Murphy, G. P. et al: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven Publishers, 1997
13. Donohue, J. P., Thornhill, J. A., Foster, R. S., Rowland, R. G. and Bihrle, R.: Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact of ejaculation. J Urol, 149: 237, 1993
14. Sogani, P. C., Perrotti, M., Herr, H. W., Fair, W. R., Thaler, H. T. and Bosl, G.: Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol, 159: 855, 1998
15. Read, G., Stenning, S. P., Cullen, M. H., Parkinson, M. C., Horwich, A., Kaye, S. B. et al: Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol, 10: 1762, 1992
16. Logothetis, C. J., Samuels, M. L., Trindade, A. and Johnson, D. E.: The growing teratoma syndrome. Cancer, 50: 1629, 1982
17. Sheinfeld, J. and Bajorin, D.: Management of the postchemotherapy residual mass. Urol Clin North Am, 20: 133, 1993
18. Motzer, R. J., Amsterdam, A., Prieto, V., Sheinfeld, J., Murty, V. V. V. S., Mazumdar, M. et al: Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol, 159: 133, 1998
19. Bredael, J. J., Vugrin, D. and Whitmore, W. F., Jr.: Recurrences in surgical stage I nonseminomatous germ cell tumors of the testis. J Urol, 130: 476, 1983
20. Sweeney, C. J., Hermans, B. P., Heilman, D. K., Foster, R. S., Donohue, J. P. and Einhorn, L. H.: Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma - predominant testis cancer. J Clin Oncol, 18: 358, 2000
21. Rabbani, F., Sheinfeld, J., Farivar-Mohseni, H., Leon, A., Rentzepis, M. J., Reuter, V. E. et al: Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol, 19: 2020, 2001
22. Motzer, R. J. and Bosl, G. J.: Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumors. Urol Clin North Am, 20: 111, 1993
23. Williams, S. D., Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P. et al: Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med, 317: 1433, 1987